JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiStefano, V.
Right arrow Articles by Doherty, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiStefano, V.
Right arrow Articles by Doherty, D. G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 117, Issue 4, 425-433, 1956
Copyright © 1956 by American Society for Pharmacology and Experimental Therapeutics


THE PARMACOLOGY OF beta-AMINOETHYLISOTHIURONIUM BROMIDE IN THE CAT

Victor DiStefano 1, Daniel E. Leary 1, and David G. Doherty 1

1 Division of Pharmacology and Toxicology, Department of Radiation Biology, The University of Rochester School of Medicine and Dentistry, Rochester 20, New York, and Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee

Low doses of AET (2.5 mgm./kgm.) evoke a fall in blood pressure, bradycardia and apnea; this triad may be abolished by section of the vagi. Atropine blocks the bradycardia and hypotension but not the apnea. Gut contractions which may be abolished by atropine are also noted.

Larger doses of AET sometimes produce a biphasic blood pressure response, a fall followed by a rise. The nature of the hypertensive mechanism is obscure.

Inhibition of nictitating membrane contractions with doses of AET above 10 mgm./kgm. is mediated both by alterations in ganglionic transmission and a direct effect on the nictitating membrane.

A slight augmentation of skeletal muscle contractions is noted with larger doses of AET (15 to 20 mgm./kgm.). Convulsions and death follow doses in excess of 25 mgm./kgm.

Submitted on March 31, 1956







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1956 by the American Society for Pharmacology and Experimental Therapeutics.